Mycosis fungoides (MF) is the most frequently found cutaneous T-cell lymphoma with an unknown aetiology. Several aetiopathogenetic mechanisms have been postulated, including persistent viral or ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the presentation of ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

It is expressed by up to 50% of patients with mycosis fungoides and peripheral T-cell lymphoma (PTCL). It has a restricted expression on normal tissues. Lacutamab is granted European Medicines Agency ...

Mycosis fungoides is a rare type of blood cancer that starts in the skin. It often involves a rash that does not go away, can appear anywhere on the skin, and may be itchy. Early treatment can be ...

Peripheral and cutaneous T-cell lymphomas in the United States: A 21-year mortality analysis (1999-2020). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Considering taking supplements to treat mycosis fungoides? Below is a list of common natural remedies used to treat or reduce the symptoms of mycosis fungoides. Follow the links to read common ...

Objective: Three patients with follicular mycosis fungoides (FMF), a rare variant of folliculotropic cutaneous T-cell lymphoma, are discussed. Follicular involvement in cutaneous T-cell lymphoma ...

“The long-term follow-up data from the TELLOMAK clinical study confirms lacutamab’s meaningful clinical benefit in Sézary syndrome and mycosis fungoides and were the basis of the FDA ...

Innate Pharma has claimed long-term data from a phase 2 study show its anti-KIR3DL2 antibody has a “sustained effect” against ...

Computed tomography showed cervical, mandibular, inguinal, and axillary lymphadenopathy. We diagnosed folliculotropic mycosis fungoides with early large-cell transformation (stage IIIB). We referred ...